Sign in
4

Changes in Ownership

Apimeds Pharmaceuticals US, Inc. Filed Acc 0001474506-25-000090

Director bought 28,500 shares at $1.99 ($56,715)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Koo Jakap Director 2025-05-12 Purchase +28,500 $1.99 $56,715 643,885 D
Open-market purchases · 28,500 sh · avg $1.99 · $56,715
Loading xslF345X05/primary_doc.xml…